1.媒體來源:
CBS NEWS(美國哥倫比亞廣播公司:CBS晚間新聞開始播出於1950年，是美國最早
的晚間新聞節目，在美國電視新聞界擁有重要地位。)
2.記者署名:
NATACHA LARNAUD
3.完整新聞標題:
Researchers look into cannabis as a potential COVID-19 treatment
4.完整新聞內文:
As new daily coronavirus infections continue to break records in the U.S.,
researchers are considering whether the cannabis plant has the potential to
be used in the treatment of COVID-19.
隨著美國的確診人數每日打破新紀錄，研究者正考慮將大麻用於治療武漢肺炎
Experts from the University of Nebraska and the Texas Biomedical Research
Institute are recommending that scientists study the anti-inflammatory
properties in CBD as a potential treatment for lung inflammation caused by
the coronavirus.
內布拉斯加州大學和德州生物醫學研究所的專家建議，研究CBD中
的抗發炎特性作為治療冠狀病毒引起的肺部炎症的潛在方法。
There is no scientific evidence that cannabis or its compounds can help with
COVID-19 specifically, but in a peer-reviewed article in Brain, Behavior, and
Immunity, the authors said further research is needed to understand if CBD
can help patients infected by the virus.
目前沒有明確的證據表明大麻與其化合物對武漢肺炎有明確的效果，
但在【Brain, Behavior, and Immunity】這本期刊裡面一篇通過同儕
審查的文章指出，需要更進一步的研究來確定CBD是否可以幫助那些受
到COVID19感染的患者。
Emily Earlenbaugh, a Forbes contributor and co-founder of Mindful Cannabis
Consulting, joined CBSN to discuss the study. She explained that in severe
cases of COVID-19, the body's immune system overreacts and releases too many
cytokines, which is called a "cytokine storm."
"Cytokines will normally help to create inflammation to fight off
infections," Earlenbaugh said. "But in these extreme cases, you see so much
cytokines being released into the system that it creates a cytokine storm.
You might see high fever, inflammation, severe fatigue and nausea, and in
serious cases, it can lead to death through organ failure."
Earlenbaugh said CBD is known from previous research as an IL-6 cytokine
inhibitor, meaning it helps reduce the production of cytokines.
富比世雜誌作家、Mindful Cannabis Consulting共同創辦人Emily Earlenbaugh
指出，在嚴重的COVID-19病例中，人體的免疫系統過度反應並釋放出過
多的細胞因子，這被稱為“細胞因子風暴"，會出現高燒，發炎，嚴重的
疲勞和噁心，甚至導致器官衰竭而導致死亡。
但在先前的研究指出CBD被稱為IL-6細胞因子抑製劑，這意味著它有助於
減少細胞因子的產生。
The authors of the study wrote that one drug, Tocilizumab, resulted in the
"clearance of lung consolidation and recovery" in 90% of the 21 treated
patients. The drug, however, resulted in adverse side effects like pancreas
inflammation and hypertriglyceridemia.
Researchers then turned to cannabis, specifically CBD. The authors said that
several cannabinoids in the cannabis plant have anti-inflammatory properties.
They said CBD "has shown beneficial anti-inflammatory effects in pre-clinical
models of various chronic inflammatory diseases" and noted that the FDA
approved one CBD product to treat certain forms of epilepsy.
研究的作者寫到在經過使用一款名叫Tocilizumab的藥物來治療21個病患，
並留下了許多後遺症後，團隊開始考慮使用大麻，特別是CBD的部分。作者
表示大麻裡數種大麻素都被證明具有抗發炎的特質。
"CBD has very few side effects, so it's something that's being looked at as a
much more mild treatment that still has a lot of anti-inflammatory powers,"
Earlenbaugh told CBSN.
Earlenbaugh告訴CBSN：“ CBD幾乎沒有副作用，因此它是一種更溫和的治
療方法，且具有非常強大的消炎作用。”
The authors of the study said that CBD can help reduce anxiety in patients
and increase the production of interferons, a protein that helps the body
fight infections.
But given the early stages of this research, Earlenbaugh said she would
"definitely express caution" against using cannabis as a treatment for
COVID-19. She said some researchers have warned using the drug early on in
the infection stages could cause negative side effects.
但有鑑於目前還在研究早期，不建議使用大麻作為治療手段。
"We're pretty far away from human research that could really definitively
answer those questions for us," Earlenbaugh said. "The other reason for
caution is that cytokines are important in fighting off infections. So, we
don't want to reduce them as a preventative measure or in early stages of the
infection."
5.完整新聞連結 (或短網址):
https://risu.io/9O0J
6.備註:
醫用大麻幾乎不會爽 製劑更不會
大麻在台灣還是超級違法